Form 4 for ACET Adicet Bio, Inc.
Accepted 2022-10-14 00:00:00 ET · period of report 2022-10-12 · accession 0001209191-22-053659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-14 | 2022-10-13 | ACET | Aftab Blake | CSO | F - Tax | $15.92 | -7,933 | 43.2K | -16% | -$126.3K |
| D | 2022-10-14 | 2022-10-12 | ACET | Aftab Blake | CSO | M - OptEx | $7.38 | +3,388 | 52.8K | +7% | +$25.0K |
| D | 2022-10-14 | 2022-10-12 | ACET | Aftab Blake | CSO | S - Sale+OE | $15.40 | -1,646 | 51.2K | -3% | -$25.3K |
| D | 2022-10-14 | 2022-10-12 | ACET | Aftab Blake | CSO | M - OptEx | $0.00 | -3,388 | 56.6K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-13 | F | D | 7,933 | $15.92 | 43,243 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-12 | M | A | 3,388 | $7.38 | 52,822 | D | — | — | |
| 3 | Common | Common Stock | 2022-10-12 | S | D | 1,646 | $15.40 | 51,176 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-10-12 | M | D | 3,388 | $0.00 | 56,612 | D | $7.38 · — to 2031-10-11 | 3,388 Common Stock | (F3) A total of 60,000 shares subject to an employee stock option were granted to the Reporting Person on October 12, 2021. 25% of the shares subject to the stock option vested and became exercisable on October 12, 2022, with the remainder vesting in equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continued service with the Issuer. |